These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Picking the right road for metastatic colorectal cancer patients. Overman M; Kopetz S Oncology (Williston Park); 2008 Nov; 22(13):1482-3. PubMed ID: 19227576 [No Abstract] [Full Text] [Related]
6. [Adjuvant therapeutic procedures in colorectal cancer: indications and possibilities]. Porschen R; Bermann A Z Gastroenterol; 1993 Nov; 31 Suppl 5():35-8. PubMed ID: 8197798 [No Abstract] [Full Text] [Related]
7. Trials on preoperative chemotherapy in resectable colorectal liver metastases need prospective evaluation of predictive factors of response. Nasti G; Ottaiano A; Rosario Iaffaioli V; Berretta M; Delrio P J Clin Oncol; 2008 Aug; 26(22):3812-3; author reply 3813. PubMed ID: 18669474 [No Abstract] [Full Text] [Related]
8. Adjuvant chemotherapy for stage II and III colorectal cancer. Benson AB Clin Adv Hematol Oncol; 2011 Aug; 9(8):616-8. PubMed ID: 22236990 [No Abstract] [Full Text] [Related]
9. [Palliative chemotherapy in advanced colorectal cancer can often be administered intermittently]. Glimelius B; Berglund A; Frödin JE; Nygren P Lakartidningen; 2003 Jun; 100(26-27):2312-3. PubMed ID: 12872380 [No Abstract] [Full Text] [Related]
10. Optimum use of biologics and role of maintenance therapy in colon cancer. Marshall J Semin Oncol; 2006 Dec; 33(6 Suppl 11):S33-5. PubMed ID: 17178283 [TBL] [Abstract][Full Text] [Related]
11. [The SOR program of guidelines for clinical practice. Palliative chemotherapy as first line treatment of metastatic colorectal cancer, 2003 update]. Gastroenterol Clin Biol; 2004 Jun; 28(6-7 Pt 2):E1-71. PubMed ID: 15286580 [No Abstract] [Full Text] [Related]
12. Recent developments on the integration of biologic agents with cytotoxic chemotherapy in the treatment of advanced colorectal cancer. Chu E Clin Colorectal Cancer; 2008 Dec; 7 Suppl 2():S46. PubMed ID: 19064405 [No Abstract] [Full Text] [Related]
13. [Biomarker for chemotherapy in patients with colorectal cancer]. Matsusaka S Gan To Kagaku Ryoho; 2009 Jan; 36(1):11-4. PubMed ID: 19151559 [TBL] [Abstract][Full Text] [Related]
14. Chemoresponsiveness associated with canonical molecular changes in colorectal adenocarcinomas. Kim JC; Roh SA; Cho DH; Kim TW; Yoon SN; Kim CW; Yu CS; Kim SY; Kim YS Anticancer Res; 2009 Aug; 29(8):3115-23. PubMed ID: 19661324 [TBL] [Abstract][Full Text] [Related]
16. [Conversion therapy for colorectal cancer]. Sasaki N; Yoshino T Gan To Kagaku Ryoho; 2011 Nov; 38(11):1793-7. PubMed ID: 22164897 [No Abstract] [Full Text] [Related]
17. Therapy for colorectal cancer. Etzioni S; Rosenfeld K N Engl J Med; 2005 Apr; 352(17):1820-2; author reply 1820-2. PubMed ID: 15864824 [No Abstract] [Full Text] [Related]
18. Chemotherapy culture differences persist, but molecular insights foster change. Benowitz S J Natl Cancer Inst; 2012 Apr; 104(8):576-8. PubMed ID: 22472544 [No Abstract] [Full Text] [Related]
19. Chemotherapy for advanced colorectal cancer. Does the evidence or the doctor have the greater influence? Munday D BMJ; 2001 Jan; 322(7280):233. PubMed ID: 11159627 [No Abstract] [Full Text] [Related]